baber/WOPTO huggingface dataset:
Patent ES-238439-A1 (ES)
Title: New alpha-(halophenoxy)-propionic acids and herbicidal compositions thereof
IPC: C07C59/68
Abstract: The invention comprises alpha-(4-bromo-3 : 5 - dimethylphenoxy)-, -(3 : 4 - dichloro - 5 - methylphenoxy)- and -(3 : 4 : 5 - trichlorophenoxy)-propionic acids and salts and esters thereof. They are used in herbicidal compositions (see Group VI). The compounds are prepared by reacting a suitably substituted phenol in the form of an alkali metal salt with an alphahalopropionic acid or ester thereof, with subsequent hydrolysis of the ester if desired. The compounds may also be prepared by the process described in Specification 822,199. The sodium, potassium, ammonium, ethylamine, diethylamine and mono-, di- or tri-ethanolamine salts are specified. The preparation of the acids and salts thereof is described. 3 : 4-Dichloro-5-methylphenol is prepared by diazotizing 3 : 4-dichloro-5-methylaniline and heating the diazonium compound with aqueous sulphuric acid and sodium sulphate.ALSO:Alpha - (4 - bromo - 3 : 5 - dimethylphenoxy) -, -(3 : 4 - dichloro - 5 - methylphenoxy) - and -(3 : 4 : 5-trichlorophenoxy)-propionic acids and salts and esters thereof (see Group IV (b)) are used in herbicidal compositions. They may be used in the form of solids, solutions, emulsions or dispersions and may be compounded with inert solids, organic solvents and wetting or dispersing agents. The Provisional Specifications mention the use of the amides of the acids in compositions.
Patent FI-20185070-A1 (FI)
Title: A seat of a vehicle, comprising a movable seating surface element, and a manufacturing method and a use for such a seat
Inventor: TERVO TUOMAS
IPC: B62J1/12
Filed: 2018-01-25
Abstract: The disclosed solution comprises a seat (1) of a vehicle (100), particularly a motor vehicle (100) such as a motorcycle (100a), the seat (1) comprising a base (3) configured to be immovably attached to the vehicle (100), a movable seating element (2) movably coupled with the base (3) and configured to move in relation to the base (3) at least sideways with respect to the longitudinal axis of the vehicle (100), and means (5, 6, 7) for providing forces resisting the movement of the movable seating element (2). The disclosed solution additionally comprises a method of additively manufacturing such a seat (1) and a use of such a seat (1) in a vehicle (100), particularly a motor vehicle (100) such as a motorcycle (100a).
Patent FI-20185602-A1 (FI)
Title: Discontinuous fast-convolution based filter processing
Inventor: RENFORS MARKKU
IPC: H04L27/26
Filed: 2018-06-29
Abstract: According to an aspect, there is provided a waveform processing device. The waveform processing device comprises means for receiving an input signal comprising one or more subsequent orthogonal frequency division multiplexing, OFDM, symbol blocks each of which comprises a cyclic prefix and an OFDM data block and corresponds to one or more subbands. Further, the waveform processing device comprises means for segmenting each OFDM symbol block of the input signal into a set of a predefined number of partially overlapping signal blocks of equal length so that nonoverlapping samples of the predefined number of partially overlapping signal blocks in each set comprise, in combination, an OFDM data block. Moreover, the waveform processing device comprises means for filtering each signal block in each set and for combining the filtered signal blocks in each set using overlap‐and‐save processing to produce one or more filtered OFDM data blocks for each subband.
Patent FI-20195223-A1 (FI)
Title: Enhancement of map data
Inventor: ERKKILÄ KIMMO
IPC: G07C5/00
Filed: 2019-03-25
Abstract: According to an aspect, there is provided a computer-implemented method for enhancing map data. The method comprises applying (600) a dynamic model (106) associated with a vehicle; calculating (602), based on the dynamic model (106) of the vehicle, an effective travel distance of a wheel of the vehicle; calculating (604), based on the dynamic model (106) of the vehicle, a momentary track width; calculating (606), based on the effective travel distance of a wheel of the vehicle and the momentary track width, a momentary direction of the vehicle; calculating (608), based on the effective travel distance of the wheel and the momentary direction of the vehicle, a position of the vehicle; associating (610) the behavior of the vehicle at the position to the map data (104) at the position; and updating (612) the map data (104) at the position based on the behavior of the vehicle at the position.
Patent FI-20225010-A1 (FI)
Title: Method of producing cellulose carbamate filaments or fibres
Inventor: SIREN SAKARI
IPC: C08B15/06
Filed: 2022-01-07
Abstract: According to an example aspect of the present invention, there is provided a method of producing cellulose carbamate filaments or fibres. The method comprising the steps of providing a cellulose carbamate dope, feeding the cellulose carbamate dope into a spinning unit exhibiting an aqueous spin bath containing sulphuric acid and a dissolved aluminium compound, coagulating the cellulose carbamate to form cellulose carbamate filaments and subjecting the cellulose carbamate filaments to stretching, optional cutting to form fibres, and optional washing. Further, the method comprises chemical recycling by withdrawing a portion of the spin bath to regeneration by removing at least a part of the sodium, water and zinc ions, and recycling at least part of the regenerated aqueous spin bath to the spinning unit, wherein the withdrawn aqueous spin bath contains, at a temperature of at least 10 °C, before regeneration dissolved ammonium nitrogen in the form of ammonium sulphate in an amount of less than 20 g/l of the spin bath.
Patent HK-1026608-A1 (HK)
Title: Composition comprising ketanserin and l-carnitine for the treatment of crps
Inventor: CAVAZZA CLAUDIO
IPC: A61P25/04
Filed: 2000-06-08
Abstract: The use of ketanserin in combination with L-carnitine, some alkanoyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed for the treatment of CRPS.
Patent HK-1043475-A1 (HK)
Title: Compositions and methods for treating infections using analogues of indolicidin
Inventor: FRASER JANET RHODA
IPC: A61K47/48
Filed: 2002-07-08
Abstract: Compositions and methods for treating infections, especially bacterial infections, are provided. Indolicidin peptide analogues containing at least two basic amino acids are prepared. The analogues are administered as modified peptides, preferably containing photo-oxidized solubilizer.
Patent HK-1052123-A1 (HK)
Title: Method for preparing a puffed grain food product and a puffed grain food product
Inventor: WU REI-YOUNG AMOS
IPC: A23L1/18
Filed: 2003-05-26
Abstract: The invention provides a method for preparing a puffed grain food product having a mixture of puffable low expansion grain and puffable high expansion grain. Flavouring agents, colouring agents or mixtures thereof are absorbed into the puffable low expansion grain pieces. The treated puffable low expansion grain pieces are then mixed with the puffable high expansion grain pieces, placed in a mold, and puffed to form an edible puffed grain food product. <IMAGE>
Patent HK-1056439-A1 (HK)
Title: Non-aqueous electrolyte and lithium secondary battery
Inventor: HAMAMOTO TOSHIKAZU
IPC: H01M6/16
Filed: 2003-11-27
Abstract: A non-aqueous electrolytic solution favorably employable for a lithium secondary battery employs a non-aqueous solvent composed of a cyclic carbonate, a linear carbonate and vinylene carbonate, and shows a reduction potential of less than 1 volt, with reference to lithium, or contains chlorine atom-containing organic compounds in an amount of 10 ppm or less, in terms of chlorine atom content.
Patent HK-1057655-A1 (HK)
Title: Spark gap
Inventor: TRINKWALD JURGEN
IPC: H01T4/18
Filed: 2004-01-26
Abstract: The spark gap has preferably several series sub-spark gaps, especially those without the first response gap being connected to a capacitor. The second and each further sub-gap are connected via the capacitor to a common reference potential, especially earth. A bypass in parallel with the single or multiple spark gap has a series circuit of an auxiliary spark gap with response voltage lower than the single or multiple spark gap and a varistor(s).  The spark gap has preferably several sub-spark gaps in series, especially those without the first response gap being connected to a capacitor (6), whereby the second and each further sib-gap are connected via the capacitor to a common reference potential, especially earth. A bypass (7) connected in parallel with the single or multiple spark gap consists of a series circuit of an auxiliary spark gap (8) with a response voltage lower than that of the single or multiple spark gap and at least one varistor (9).
Patent HK-1070803-A1 (HK)
Title: System for assessing urinary function
Inventor: TRACEY MICHAEL R
IPC: A61B5/20
Filed: 2005-04-28
Abstract: A method is provided for assessing urinary function including removably coupling a first test module to a portable control device, selecting from a plurality of different tests a first test to assess urinary function, the selection being made based on first module identification information obtained by the control device from the test module, and performing the first test. The method may also include one or more of the steps of inserting an insert member coupled to the first test module at least partially into a patient's urinary tract, infusing fluid through the insert member into the urinary tract, and measuring pressure within the urinary tract as fluid is infused therein. The method may further include uncoupling the first test module from the portable control device, coupling a second test module to the portable control device, selecting a second test to assess urinary function based on second module identification information obtained by the control device from the second test module, and performing the second test.
Patent HK-1074107-A1 (HK)
Title: System and method for indexing commercials in a video presentation
Inventor: GARCIA BRUCE
IPC: H04N5/765
Filed: 2005-07-22
Abstract: Systems and methods for providing enhanced navigation of stored digital video content based upon an event index. Includes generation and storage of an event index, as well as navigation based on events in the event index. An example system is embodied in a digital video recorder that detects and stores black field and silent frame events for use in locating commercial groups. The commercial groups may be skipped or otherwise navigated based upon data pointers linking the stored events to corresponding locations in the video data file.
Patent HK-1074774-A1 (HK)
Title: Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
Inventor: FELDMAN DAVID LOUIS
IPC: A61K31/4409
Filed: 2005-08-12
Abstract: The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB), and (iii) a diuretic and to a method of treatment of a condition or a disease selected from the group consisting of hypertension, heart failure such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy, supraventricular and ventricular arrhythmias, atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae, atherosclerosis, angina (whether unstable or stable), renal insufficiency (diabetic and non- diabetic), heart failure, angina pectoris, diabetes, secondary aldosteronism, primary and secondary pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis (including IgA nephropathy), renal fibrosis, scleroderma, glomerular sclerosis, proteinuria of renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, peripheral vascular disease, Raynaud's disease, luminal hyperplasia, cognitive dysfunction (such as Alzheimer's), glaucoma and stroke, pulmonary and hepatic fibrosis, fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF, and proliferative diseases of smooth muscle cells, including uterine fibroids comprising administering a therapeutically effective amount of said pharmaceutical composition to a mammal in need of such treatment.
Patent HK-1080553-A1 (HK)
Title: Optical fiber connector assembly
Inventor: WEYNANT ERIC
IPC: G02B/
Filed: 2005-12-28
Abstract: The present invention is directed to an optical fiber (12,14) connector (10) comprising a longitudinally extending body (16), said body (16) comprising a first end (18) and a second end (20), and said body having a conduit (22) extending from said first end (18) to said second end (20), and said body (16) comprising a plurality of finger projections (24,26) that extend longitudinally at each end of said first (18) and second ends (20), the connector assembly (10) including a first collar circumferentially coupled to said first end (18) of said connector (10) and a second collar (36) circumferentially coupled to said second end (20) of said connector (10), the connector assembly (10) comprises a connector housing of four portions (38), which, when assembled, define a connector chamber for receiving and retaining a connector (10) as aforesaid.
Patent HK-1079466-A1 (HK)
Title: Needleless medical connector with expandable valve mechanism
Inventor: LEINSING KARL R
IPC: A61L2/16
Filed: 2006-02-14
Abstract: A needleless connector (10) for medical use, adapted to facilitate the flow of fluid therethrough, includes a housing (12) having an inlet port (14) and an outlet port (18). The connector also includes a flex-tube assembly (22) defining a fluid path between the inlet port and the outlet port. The flex-tube assembly is movable between uncompressed and compressed states. The flex-tube assembly has a first internal volume when in the uncompressed state and a second internal volume, greater than or substantially equal to the first internal volume, when in the compressed state. <IMAGE>
Patent HK-1082459-A1 (HK)
Title: Screen system, screen component and its installation method, vibrating screen device and particle screening method
Inventor: FISCHER GEORGE WILLOX
IPC: B07B1/48
Filed: 2006-04-04
Abstract: The present invention provides a screen system (8) suitable for use in a vibratory screen apparatus (1), and comprising: a screen element (11) and a support frame (12) therefor, as well as novel screen elements (11) and mesh panels (19) therefor, and the use thereof. The screen element (11) consists essentially of a mesh panel (19) provided with first and second elongate support members (22, 23) extending along opposite end portions of the mesh panel (19). The support frame (12) has spaced apart first and second elongate frame elements (13, 14) for engagement with the screen element support members (22, 23) and further elongate frame elements (17, 18) extending there between for supporting the mesh panel (19). The screen element support members (22, 23) and said first and second frame elements (13, 14) are formed and arranged for secure interengagement in use of the screen system, with at least one of said screen element support members and the respective one of said first and second frame elements being formed and arranged so that when clamped together, the mesh panel (19) is securely held under tension against said further frame elements (17, 18).
Patent HK-1107774-A1 (HK)
Title: 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues useful as inhibitors of macrophage elastase ;
Inventor: YANG FUDE
IPC: A61K/
Filed: 2008-02-11
Abstract: 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and analogues useful as inhibitors of macrophage elastase are disclosed.
Patent HK-1113390-A1 (HK)
Title: Modification of plant development and morphology
Inventor: THOMAS CHRISTOPHER JOHN ROBERT
IPC: C12N/
Filed: 2008-03-28
Abstract: A method of modifying morphology in a plant by introducing into a plant at least one chimaeric gene having a promoter sequence operably associated with a nucleic acid sequence, the promoter sequence being operable to direct expression in specific cells of the plant and the nucleic acid sequence encoding at least one gene product capable of altering the metabolism of or causing death of the specific cells and/or nearby cells. In particular, the promoter sequence is operable to direct expression in lateral bud or lateral shoot and the nucleic acid encoding at least one gene product capable of disrupting the metabolism of or causing the death of the lateral bud or lateral shoot of nearby cells. Preferably the promoter sequence has the sequence shown as SEQ ID No. 1 or SEQ ID No. 7 or SEQ ID No. 4, or a part thereof capable of regulating expression of a gene, or a sequence having at least 60%, preferably at least 75%, homology to SEQ ID No. 1 or SEQ ID No. 7 or SEQ ID No. 4 and being capable of regulating expression of a gene.
Patent HK-1116928-A1 (HK)
Title: Alkaline cell anode casing
Inventor: GUO JINGDONG
IPC: H01M50/119
Filed: 2008-07-08
Abstract: The invention is an electrochemical cell with a zinc-containing negative electrode, an aqueous alkaline electrolyte and a cup-shaped metal negative electrode casing in contact with the negative electrode. The negative electrode casing is formed from a substrate that is substantially free of copper and at least those portions of the surface of the negative electrode casing in the seal area and the current collector area are coated with a layer of an alloy comprising copper, tin and zinc. The alloy layer reduces hydrogen gassing within the cell and is particularly useful in cells with no added mercury. Embodiments of the invention include cells with prismatic, cylindrical and button shaped containers and cells with positive electrode active materials including manganese dioxide, silver oxide and oxygen.
Patent HK-1120865-A1 (HK)
Title: Prognostic allergy test
Inventor: SAMPSON HUGH A
IPC: G01N33/569
Filed: 2008-12-31
Abstract: One can predict the likelihood a child will outgrow an allergy, especially a food allergy, by screening for IgE antibodies immunoreactivities with linear versus conformational epitopes. The child is first screened using standard techniques to determine what antigens the child is allergic to. The immunoglobulins in the sample from the patient are then characterised either using the natural purified antigen, recombinant antigen, reduced and alkylated antigen, proteolytic fragments of the antigen or synthetic peptides of between 4 and 40 amino acids in length, which can be immobilised for rapid and accurate screening. The antibodies from the patient are reacted with the protein or peptides to determine which peptides are bound by the antibodies. These antibodies are then characterised to determine if the epitopes they bind are linear or conformational. Those patients having antibodies primarily reactive with conformational epitopes will typically outgrow their allergies. A similar method for evaluation of IgG antibodies can be used to predict the prognosis of certain inflammatory disorders.
Patent HK-1123275-A1 (HK)
Title: Novel method for preparing quaternary acid and ammonium salts
Inventor: DELLIS PHILIPPE
IPC: A61K/
Filed: 2009-01-02
Abstract: A process for preparing a quaternary ammonium salt of a fibric acid, represented by the following reaction scheme: is carried out in a single operation starting from a phenol of formula (I), an α-halogenated ester of formula (II) and a quaternary ammonium hydroxide of formula (III). This process makes it possible economically to prepare a choline salt of fenofibric acid in high purity that can be used directly as the active substance in a pharmaceutical composition intended for human consumption.
Patent HK-1123774-A1 (HK)
Title: A method of producing perforated retroreflective trim
Inventor: BRENNAN CHRISTOPHER JOHN
IPC: B32B/
Filed: 2009-04-22
Abstract: A method for producing a perforated retroreflective trim that includes the steps of providing a substrate having first and second sides and a plurality of openings extending between the sides, providing a backing on the first side of the substrate, providing a retroreflective layer on the second side of the substrate, adhering the retroreflective layer to the second side of the substrate and to the backing within the openings of the substrate so that portions of the retroreflective layer are adhered to the backing through the openings in the substrate, and removing the backing from the first side of the substrate to strip away from the retroreflective layer the portions of the retroreflective layer adhered to the backing through the openings in the substrate to provide the perforated retroreflective trim.
Patent HK-1144702-A1 (HK)
Title: Anti-glypican-3 antibody having improved kinetics in plasma
Inventor: IGAWA TOMOYUKI
IPC: A61K/
Filed: 2010-12-01
Abstract: A method of modulating the plasma half-life of anti-glypican 3 antibody, a pharmaceutical composition comprising as an effective component the anti-glypican 3 antibody that has a plasma half-life that has been modulated, a method of preparing the anti-glypican 3 antibody and a pharmaceutical composition comprising the anti-glypican 3 antibody as an effective component are provided. Disclosed is a method of modulating the plasma half-life of anti-glypican 3 antibody by modifying an amino acid residue that is exposed on the surface of the anti-glypican 3 antibody; and anti-glypican 3 antibody that has a plasma half-life that has been modulated by amino acid residue modification, a pharmaceutical composition comprising as an effective component the anti-glypican 3 antibody, and a method of preparing the anti-glypican 3 antibody and producing a pharmaceutical composition comprising the anti-glypican 3 antibody as an effective component.
Patent HK-1147098-A1 (HK)
Title: Deuterated etravirine
Inventor: MASSE CRAIG E
IPC: A61K/
Filed: 2011-02-02
Abstract: This disclosure relates to novel di-aryl-pyrimidine (DAPY) compounds and pharmaceutically acceptable salts thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Patent HK-1155928-A1 (HK)
Title: In vivo micro-invasive investigation device including a metal guide
Inventor: POMPIDOU ALAIN
IPC: A61B/
Filed: 2011-10-03
Abstract: The device has a microinvasive or micro-sampling investigating system comprising a flexible metallic guide with an end containing a series of pits. The pits are directly coupled to a specific reactive group of a substrate, where the end is perforated. Another end of the metallic guide is used to maneuver the metallic guide and associated with an aspiration system. A removable protection system e.g. flexible catheter, is arranged at the former end of the metallic guide. An independent claim is also included for a method for detecting ex vivo of a substrate present in a tissue or organ.
Patent HK-1000919-A1 (HK)
Title: Hydrazones
Inventor: STANEK JAROSLAV
IPC: A61K31/155
Filed: 1997-11-06
Abstract: Compounds of the formula I <IMAGE> in which A denotes a direct bond or -(CH2)n-, in which n represents 1, 2 or 3; X represents a -C(=Y)-NR6R7 radical; Y represents NR8, O or S; Z represents NR9, O or S; R1 and R2, independently of one another, denote hydrogen or one or more substituents other than hydrogen; the radicals R3, R4, R6, R8 and R9 independently of one another denote hydrogen or lower alkyl; and R5 and R7 independently of one another represent hydrogen, lower alkyl, hydroxyl, etherified or esterified hydroxyl or unsubstituted or mono- or disubstituted amino; tautomers thereof, and salts thereof. They have useful pharmaceutical properties and are particularly active against tumours. They are prepared in a manner known per se.